Xufei Huang

机构：Fujian Medical University, Fujian Provincial Hospital, Union Hospital · ORCID：0000-0002-4666-2144

发表论文 34 篇 · 总被引 383 次 · h-index 10

代表论文

• A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome (2018 · American Journal of Hematology · 被引 73)
• What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone? (2019 · Leukemia · 被引 62)
• Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome (2016 · Leukemia Research · 被引 49)
• The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients (2016 · Leukemia Research · 被引 30)
• Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role? (2017 · Blood Reviews · 被引 26)
• Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome (2018 · Blood Cancer Journal · 被引 24)